Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
It aids in the production of melatonin, which regulates sleep and wake cycles, as well as serotonin, which influences deep sleep and wakefulness
Patience is part of the deal
A portion of those who start on the drugs discontinue their use, and among these people, food purchases rebound
Supplied as a high-purity lyophilized powder for controlled in vitro laboratory research use only
From a clinical perspective, patient selection, dosage control, and skilled administration are essential to achieving safe and predictable outcomes
US$ 21.45
US$ 26.39
US$ 22.28
US$ 21.83
US$ 20.51
US$ 20.79
US$ 22.49
US$ 20.46
